Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, T. F.
Right arrow Articles by Bilchik, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, T. F.
Right arrow Articles by Bilchik, A. J.
Related Collections
Right arrow Ablative therapies

Annals of Surgical Oncology, Vol 7, Issue 8 593-600, Copyright © 2000 by Society of Surgical Oncology

ARTICLES

Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications

T. F. Wood, D. M. Rose, M. Chung, D. P. Allegra, L. J. Foshag and A. J. Bilchik
Department of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA.

BACKGROUND: Radiofrequency ablation (RFA) is increasingly used for the local destruction of unresectable hepatic malignancies. There is little information on its optimal approach or potential complications. METHODS: Since late 1997, we have undertaken 91 RFA procedures to ablate 231 unresectable primary or metastatic liver tumors in 84 patients. RFA was performed via celiotomy (n = 39), laparoscopy (n = 27), or a percutaneous approach (n = 25). Patients were followed with spiral computed tomographic (CT) scans at 1 to 2 weeks postprocedure and then every 3 months for 2 years. RESULTS: Intraoperative ultrasound (IOUS) detected intrahepatic disease not evident on the preoperative scans of 25 of 66 patients (38%) undergoing RFA via celiotomy or laparoscopy. In 38 of 84 patients (45%), RFA was combined with resection or cryosurgical ablation (CSA), or both. RFA was used to treat an average of 2.8 lesions per patient, and the median size of treated lesions was 2 cm (range, 0.3-9 cm). The average hospital stay was 3.6 days overall (1.8 days for percutaneous and laparoscopic cases). Ten patients underwent a second RFA procedure (sequential ablations) and, in one case, a third RFA procedure for large (one patient), progressive (seven patients), and/or recurrent (three patients) lesions. Seven (8%) patients had complications: one skin burn; one postoperative hemorrhage; two simple hepatic abscesses; one hepatic abscess associated with diaphragmatic heat necrosis following sequential percutaneous ablations of a large lesion; one postoperative myocardial infarction; and one liver failure. There were three deaths, one (1%) of which was directly related to the RFA procedure. Three of the complications, including one RFA-related death, occurred after percutaneous RFA. At a median follow-up of 9 months (range, 1-27 months), 15 patients (18%) had recurrences at an RFA site, and 36 patients (43%) remained clinically free of disease. CONCLUSIONS: Celiotomy or laparoscopic approaches are preferred for RFA because they allow IOUS, which may demonstrate occult hepatic disease. Operative RFA also allows concomitant resection, CSA, or placement of a hepatic artery infusion pump, and isolation of the liver from adjacent organs. Percutaneous RFA should be reserved for patients at high risk for anesthesia, those with recurrent or progressive lesions, and those with smaller lesions sufficiently isolated from adjacent organs. Complications may be minimized when these approaches are applied selectively.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
E. Berber and A. Siperstein
Local Recurrence After Laparoscopic Radiofrequency Ablation of Liver Tumors: An Analysis of 1032 Tumors
Ann. Surg. Oncol., October 1, 2008; 15(10): 2757 - 2764.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
Y.-s. Kim, H. Rhim, H. K. Lim, D. Choi, W. J. Lee, T. Y. Jeon, J. W. Joh, and S. J. Kim
Intraoperative Radiofrequency Ablation for Hepatocellular Carcinoma: Long-Term Results in a Large Series
Ann. Surg. Oncol., July 1, 2008; 15(7): 1862 - 1870.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
E. J. Lee, H. Rhim, H. K. Lim, D. Choi, W. J. Lee, and K. S. Min
Effect of Artificial Ascites on Thermal Injury to the Diaphragm and Stomach in Radiofrequency Ablation of the Liver: Experimental Study with a Porcine Model
Am. J. Roentgenol., June 1, 2008; 190(6): 1659 - 1664.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
J. Lee, H. Rhim, Y. H. Jeon, H. K. Lim, W. J. Lee, D. Choi, and Y.-s. Kim
Radiofrequency Ablation of Liver Adjacent to Body of Gallbladder: Histopathologic Changes of Gallbladder Wall in a Pig Model
Am. J. Roentgenol., February 1, 2008; 190(2): 418 - 425.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. Mulier, Y. Ni, J. Jamart, L. Michel, G. Marchal, and T. Ruers
Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?
Ann. Surg. Oncol., January 1, 2008; 15(1): 144 - 157.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
T. M. Pawlik, R. D. Schulick, and M. A. Choti
Expanding Criteria for Resectability of Colorectal Liver Metastases
Oncologist, January 1, 2008; 13(1): 51 - 64.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
M. R. Khan, R. T. P. Poon, K. K. Ng, A. C. Chan, J. Yuen, H. Tung, J. Tsang, and S. T. Fan
Comparison of Percutaneous and Surgical Approaches for Radiofrequency Ablation of Small and Medium Hepatocellular Carcinoma
Arch Surg, December 1, 2007; 142(12): 1136 - 1143.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
P. Kornprat, W. R. Jarnagin, R. P. DeMatteo, Y. Fong, L. H. Blumgart, and M. D'Angelica
Role of Intraoperative Thermoablation Combined With Resection in the Treatment of Hepatic Metastasis From Colorectal Cancer
Arch Surg, November 1, 2007; 142(11): 1087 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
F. M. Vogt, G. Antoch, P. Veit, L. S. Freudenberg, N. Blechschmid, O. Diersch, A. Bockisch, J. Barkhausen, and H. Kuehl
Morphologic and Functional Changes in Nontumorous Liver Tissue After Radiofrequency Ablation in an In Vivo Model: Comparison of 18F-FDG PET/CT, MRI, Ultrasound, and CT
J. Nucl. Med., November 1, 2007; 48(11): 1836 - 1844.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
Y.-J. Zhang, H.-H. Liang, M.-S. Chen, R.-P. Guo, J.-Q. Li, Y. Zheng, Y.-Q. Zhang, and W. Y. Lau
Hepatocellular Carcinoma Treated with Radiofrequency Ablation with or without Ethanol Injection: A Prospective Randomized Trial
Radiology, August 1, 2007; 244(2): 599 - 607.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
H. W. Head, G. D. Dodd III, N. C. Dalrymple, S. R. Prasad, F. M. El-Merhi, M. W. Freckleton, and L. G. Hubbard
Percutaneous Radiofrequency Ablation of Hepatic Tumors against the Diaphragm: Frequency of Diaphragmatic Injury
Radiology, June 1, 2007; 243(3): 877 - 884.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. Mulier, Y. Ni, L. Frich, F. Burdio, A. L. Denys, J.-F. De Wispelaere, B. Dupas, N. Habib, M. Hoey, M. C. Jansen, et al.
Experimental and Clinical Radiofrequency Ablation: Proposal for Standardized Description of Coagulation Size and Geometry
Ann. Surg. Oncol., April 1, 2007; 14(4): 1381 - 1396.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
K. S. Chok, K. K. Ng, R. T. P. Poon, C. M. Lam, J. Yuen, W. K. Tso, and S. T. Fan
Comparable Survival in Patients With Unresectable Hepatocellular Carcinoma Treated by Radiofrequency Ablation or Transarterial Chemoembolization
Arch Surg, December 1, 2006; 141(12): 1231 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. K. Abdalla, R. Adam, A. J. Bilchik, D. Jaeck, J.-N. Vauthey, and D. Mahvi
Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement
Ann. Surg. Oncol., October 1, 2006; 13(10): 1271 - 1280.
[Full Text] [PDF]

Home page
 Arch SurgHome page
T. M. Pawlik, J.-N. Vauthey, E. K. Abdalla, R. E. Pollock, L. M. Ellis, and S. A. Curley
Results of a Single-Center Experience With Resection and Ablation for Sarcoma Metastatic to the Liver
Arch Surg, June 1, 2006; 141(6): 537 - 544.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
F. F. Amersi, A. McElrath-Garza, A. Ahmad, T. Zogakis, D. P. Allegra, R. Krasne, and A. J. Bilchik
Long-term Survival After Radiofrequency Ablation of Complex Unresectable Liver Tumors
Arch Surg, June 1, 2006; 141(6): 581 - 588.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
F. H. van Duijnhoven, M. C. Jansen, J. M. C. Junggeburt, R. van Hillegersberg, A. M. Rijken, F. van Coevorden, J. R. van der Sijp, T. M. van Gulik, G. D. Slooter, J. M. Klaase, et al.
Factors Influencing the Local Failure Rate of Radiofrequency Ablation of Colorectal Liver Metastases
Ann. Surg. Oncol., May 1, 2006; 13(5): 651 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. Shibuya, T. Nakazawa, K. Saigenji, K. Furuta, and K. Matsunaga
Diaphragmatic hernia after radiofrequency ablation therapy for hepatocellular carcinoma.
Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S241 - S243.
[Full Text] [PDF]

Home page
 RadiologyHome page
T. M. Wah, R. S. Arellano, D. A. Gervais, C. A. Saltalamacchia, J. Martino, E. F. Halpern, M. Maher, and P. R. Mueller
Image-guided Percutaneous Radiofrequency Ablation and Incidence of Post-Radiofrequency Ablation Syndrome: Prospective Survey
Radiology, December 1, 2005; 237(3): 1097 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
R. J. Canter, S. B. Kesmodel, D. F. Heitjan, N. K. Veeramachaneni, N. A. Mokadam, J. A. Drebin, and D. L. Fraker
Suppression of {beta}-Catenin by Antisense Oligomers Augments Tumor Response to Isolated Limb Perfusion in a Rodent Model of Adenomatous Polyposis Coli-Mutant Colon Cancer
Ann. Surg. Oncol., September 1, 2005; 12(9): 733 - 742.
[Abstract] [Full Text] [PDF]

Home page
 J Ultrasound MedHome page
H. Tamai, M. Oka, H. Maeda, N. Shingaki, T. Kanno, S. Enomoto, T. Shiraki, M. Iguchi, K. Nakazawa, K. Arii, et al.
Contrast Harmonic Sonographically Guided Radio Frequency Ablation for Spontaneous Ruptured Hepatocellular Carcinoma
J. Ultrasound Med., July 1, 2005; 24(7): 1021 - 1026.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
G. D. Dodd III, D. Napier, J. D. Schoolfield, and L. Hubbard
Percutaneous Radiofrequency Ablation of Hepatic Tumors: Postablation Syndrome
Am. J. Roentgenol., July 1, 2005; 185(1): 51 - 57.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. S. Wright, L. A. Sampson, T. F. Warner, D. M. Mahvi, and F. T. Lee Jr
Radiofrequency versus Microwave Ablation in a Hepatic Porcine Model
Radiology, July 1, 2005; 236(1): 132 - 139.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
D. Choi, H. K. Lim, M. J. Kim, S. J. Kim, S. H. Kim, W. J. Lee, J. H. Lim, S. W. Paik, B. C. Yoo, M. S. Choi, et al.
Liver Abscess After Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Frequency and Risk Factors
Am. J. Roentgenol., June 1, 2005; 184(6): 1860 - 1867.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. Ahmed, Z. Liu, A. N. Lukyanov, S. Signoretti, C. Horkan, W. L. Monsky, V. P. Torchilin, and S. N. Goldberg
Combination Radiofrequency Ablation with Intratumoral Liposomal Doxorubicin: Effect on Drug Accumulation and Coagulation in Multiple Tissues and Tumor Types in Animals
Radiology, May 1, 2005; 235(2): 469 - 477.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
K. K. Ng, C. M. Lam, R. T. Poon, T. W. Shek, W. C. Yu, J. Y. To, Y. H. Wo, C. P. Lau, T. C. Tang, D. W. Ho, et al.
Porcine Liver: Morphologic Characteristics and Cell Viability at Experimental Radiofrequency Ablation with Internally Cooled Electrodes
Radiology, May 1, 2005; 235(2): 478 - 486.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. Giorgio, L. Tarantino, G. de Stefano, C. Coppola, and G. Ferraioli
Complications After Percutaneous Saline-Enhanced Radiofrequency Ablation of Liver Tumors: 3-Year Experience with 336 Patients at a Single Center
Am. J. Roentgenol., January 1, 2005; 184(1): 207 - 211.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
S. H. Kim, H. K. Lim, D. Choi, W. J. Lee, S. H. Kim, M. J. Kim, S. J. Lee, and J. H. Lim
Changes in Bile Ducts after Radiofrequency Ablation of Hepatocellular Carcinoma: Frequency and Clinical Significance
Am. J. Roentgenol., December 1, 2004; 183(6): 1611 - 1617.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
A R Gillams
Liver ablation therapy
Br. J. Radiol., September 1, 2004; 77(921): 713 - 723.
[Full Text] [PDF]

Home page
 Arch SurgHome page
E. W. Johnson, P. S. Holck, A. E. Levy, M. M. Yeh, and R. S. Yeung
The Role of Tumor Ablation in Bridging Patients to Liver Transplantation
Arch Surg, August 1, 2004; 139(8): 825 - 830.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. J. Bilchik and S. R. Martinez
Editorial: Novel Effective Drugs and Evolving Ablation Technology: A More Comprehensive Approach to Hepatic Malignancies
Ann. Surg. Oncol., May 1, 2004; 11(5): 458 - 459.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. K. Abdalla and J.-N. Vauthey
Editorial: Technique and Patient Selection, Not the Needle, Determine Outcome of Percutaneous Intervention for Hepatocellular Carcinoma
Ann. Surg. Oncol., March 1, 2004; 11(3): 240 - 241.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
R. T.-P. Poon, K. K.-C. Ng, C.-M. Lam, V. Ai, J. Yuen, and S.-T. Fan
Radiofrequency Ablation for Subcapsular Hepatocellular Carcinoma
Ann. Surg. Oncol., March 1, 2004; 11(3): 281 - 289.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. Fuss and C. R. Thomas Jr.
Stereotactic Body Radiation Therapy: An Ablative Treatment Option for Primary and Secondary Liver Tumors
Ann. Surg. Oncol., February 1, 2004; 11(2): 130 - 138.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
R. P. Owen, C. E. Silver, T. S. Ravikumar, A. Brook, J. Bello, and D. Breining
Techniques for Radiofrequency Ablation of Head and Neck Tumors
Arch Otolaryngol Head Neck Surg, January 1, 2004; 130(1): 52 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
T. M. Pawlik, F. Izzo, D. S. Cohen, J. S. Morris, and S. A. Curley
Combined Resection and Radiofrequency Ablation for Advanced Hepatic Malignancies: Results in 172 Patients
Ann. Surg. Oncol., November 1, 2003; 10(9): 1059 - 1069.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
T. de Baere, O. Risse, V. Kuoch, C. Dromain, C. Sengel, T. Smayra, M. G. E. Din, C. Letoublon, and D. Elias
Adverse Events During Radiofrequency Treatment of 582 Hepatic Tumors
Am. J. Roentgenol., September 1, 2003; 181(3): 695 - 700.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. Koda, M. Ueki, N. Maeda, and Y. Murawaki
Diaphragmatic Perforation and Hernia After Hepatic Radiofrequency Ablation
Am. J. Roentgenol., June 1, 2003; 180(6): 1561 - 1562.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. A. Curley
Radiofrequency Ablation of Malignant Liver Tumors
Ann. Surg. Oncol., May 1, 2003; 10(4): 338 - 347.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. L. Scaife, S. A. Curley, F. Izzo, P. Marra, P. Delrio, B. Daniele, F. Cremona, J. E. Gershenwald, J. L. Chase, R. D. Lozano, et al.
Feasibility of Adjuvant Hepatic Arterial Infusion of Chemotherapy After Radiofrequency Ablation With or Without Resection in Patients With Hepatic Metastases From Colorectal Cancer
Ann. Surg. Oncol., May 1, 2003; 10(4): 348 - 354.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. S. Wright, F. T. Lee Jr, and D. M. Mahvi
Hepatic Microwave Ablation With Multiple Antennae Results in Synergistically Larger Zones of Coagulation Necrosis
Ann. Surg. Oncol., April 1, 2003; 10(3): 275 - 283.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
T. Livraghi, L. Solbiati, M. F. Meloni, G. S. Gazelle, E. F. Halpern, and S. N. Goldberg
Treatment of Focal Liver Tumors with Percutaneous Radio-frequency Ablation: Complications Encountered in a Multicenter Study
Radiology, February 1, 2003; 226(2): 441 - 451.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
R. J. Bleicher, D. P. Allegra, D. T. Nora, T. F. Wood, L. J. Foshag, and A. J. Bilchik
Radiofrequency Ablation in 447 Complex Unresectable Liver Tumors: Lessons Learned
Ann. Surg. Oncol., January 1, 2003; 10(1): 52 - 58.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
H. Rhim, K.-H. Yoon, J. M. Lee, Y. Cho, J.-S. Cho, S. H. Kim, W.-J. Lee, H. K. Lim, G.-J. Nam, S.-S. Han, et al.
Major Complications after Radio-frequency Thermal Ablation of Hepatic Tumors: Spectrum of Imaging Findings
RadioGraphics, January 1, 2003; 23(1): 123 - 134.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
R. Adam, E. J. Hagopian, M. Linhares, J. Krissat, E. Savier, D. Azoulay, F. Kunstlinger, D. Castaing, and H. Bismuth
A Comparison of Percutaneous Cryosurgery and Percutaneous Radiofrequency for Unresectable Hepatic Malignancies
Arch Surg, December 1, 2002; 137(12): 1332 - 1339.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B.S. Langenhoff, W.J.G. Oyen, G.J. Jager, S.P. Strijk, Th. Wobbes, F.H.M. Corstens, and T.J.M. Ruers
Efficacy of Fluorine-18-Deoxyglucose Positron Emission Tomography in Detecting Tumor Recurrence After Local Ablative Therapy for Liver Metastases: A Prospective Study
J. Clin. Oncol., November 15, 2002; 20(22): 4453 - 4458.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
T. J. Vogl, R. Straub, K. Eichler, D. Woitaschek, and M. G. Mack
Malignant Liver Tumors Treated with MR Imaging-guided Laser-induced Thermotherapy: Experience with Complications in 899 Patients (2,520 lesions)
Radiology, November 1, 2002; 225(2): 367 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. C. Conlon and R. L. McMahon
Minimally Invasive Surgery in the Diagnosis and Treatment of Upper Gastrointestinal Tract Malignancy
Ann. Surg. Oncol., October 1, 2002; 9(8): 725 - 737.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C.K. Chang, M. P. Hendy, J. M. Smith, M. H. Recht, and R. E. Welling
Radiofrequency Ablation of the Porcine Liver With Complete Hepatic Vascular Occlusion
Ann. Surg. Oncol., July 1, 2002; 9(6): 594 - 598.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
D. A. Iannitti, D. E. Dupuy, W. W. Mayo-Smith, and B. Murphy
Hepatic Radiofrequency Ablation
Arch Surg, April 1, 2002; 137(4): 422 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
T. Yamagami, T. Nakamura, T. Kato, S. Matsushima, S. Iida, and T. Nishimura
Skin Injury After Radiofrequency Ablation for Hepatic Cancer
Am. J. Roentgenol., April 1, 2002; 178(4): 905 - 907.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. A. Litvak, T. F. Wood, G. J. Tsioulias, M. Chung, S. P. Chawla, L. J. Foshag, D. L. Morton, K. P. Ramming, and A. J. Bilchik
Systemic Irinotecan and Regional Floxuridine After Hepatic Cytoreduction in 185 Patients With Unresectable Colorectal Cancer Metastases
Ann. Surg. Oncol., March 1, 2002; 9(2): 148 - 155.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
J N Primrose
Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation
Gut, January 1, 2002; 50(1): 1 - 5.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
H. Choi, E. M. Loyer, R. A. DuBrow, H. Kaur, C. L. David, S. Huang, S. Curley, and C. Charnsangavej
Radio-frequency Ablation of Liver Tumors: Assessment of Therapeutic Response and Complications
RadioGraphics, October 1, 2001; 21(90001): S41 - 54.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
A. J. Bilchik, T. F. Wood, and D. P. Allegra
Radiofrequency Ablation of Unresectable Hepatic Malignancies: Lessons Learned
Oncologist, February 1, 2001; 6(1): 24 - 33.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society of Surgical Oncology.